Medpage Today: Reassuring Registry Data on Going Into TAVR Sans Symptoms

Transcatheter aortic valve replacement (TAVR) got some preliminary affirmation for asymptomatic or minimally symptomatic severe aortic stenosis in a retrospective registry study.

Of participants who got elective TAVR, the one in five who had minimal symptoms before the procedure tended to have good outcomes that compared favorably against the majority of more symptomatic peers.

Chetan Huded, MD, MSc, of Saint Luke's Mid America Heart Institute in Kansas City, Missouri, and colleagues concluded that "the results of our study support the hypothesis that TAVR in minimally symptomatic patients may be beneficial to prevent the anticipated deterioration of health status, although without a comparison with nontreated patients, this hypothesis cannot be formally tested."

Read the full Medpage Today article: Reassuring Registry Data on Going Into TAVR Sans Symptoms

Related Content

Sep. 21, 2023

Healio: Minimally Symptomatic Patients Likely to Survive with Good Health Status After TAVR

Dr. Chetan Huded and colleagues found patients with minimal symptoms who underwent TAVR were more likely to survive with good health status at one year than more symptomatic patients.
Sep. 15, 2023

Physician's Weekly: Cardiac Arrest Survival Lower at EMS Agencies Serving Minority Populations
Dr. Anezi Uzendu and colleagues examined whether EMS agencies that work in Black and Hispanic communities have lower survival rates for OHCA than agencies in White communities.
Sep. 7, 2023

KSHB: Kansas City Doctors Are at Center of Breakthrough Research for Heart Failure Patients
KSHB talked to Dr. Mikhail Kosiborod, a cardiologist at Saint Luke’s Mid America Heart Institute and the study’s lead investigator, and Nancy Collins, a patient who was enrolled in the study.